Accessibility Menu
 
GSK logo

GSK

(NYSE) GSK

Current Price$51.88
Market Cap$103.77B
Since IPO (2000)+182%
5 Year+70%
1 Year+37%
1 Month-15%

GSK Financials at a Glance

Market Cap

$103.77B

Revenue (TTM)

$32.67B

Net Income (TTM)

$5.72B

EPS (TTM)

$3.66

P/E Ratio

13.95

Dividend

$1.78

Beta (Volatility)

0.26 (Low)

Price

$51.88

Volume

4,637,321

Open

$52.17

Previous Close

$51.84

Daily Range

$51.55 - $52.40

52-Week Range

$32.38 - $61.70

GSK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GSK

Industry

Pharmaceuticals

Employees

66,841

CEO

Emma N. Walmsley

Headquarters

Brentford, TW8 9GS, GB

GSK Financials

Key Financial Metrics (TTM)

Gross Margin

72%

Operating Margin

22%

Net Income Margin

17%

Return on Equity

38%

Return on Capital

18%

Return on Assets

9%

Earnings Yield

7.17%

Dividend Yield

0.03%

Payout Ratio

44.86%

Stock Overview

Market Cap

$103.77B

Shares Outstanding

2.00B

Volume

4.64M

Short Interest

0.00%

Avg. Volume

5.25M

Financials (TTM)

Gross Profit

$23.18B

Operating Income

$7.01B

EBITDA

$11.62B

Operating Cash Flow

$7.14B

Capital Expenditure

$1.32B

Free Cash Flow

$5.82B

Cash & ST Invst.

$3.40B

Total Debt

$17.69B

GSK Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$8.62B

+6.2%

Gross Profit

$6.01B

+8.1%

Gross Margin

69.70%

N/A

Market Cap

$103.77B

N/A

Market Cap/Employee

$1.51M

N/A

Employees

68,629

N/A

Net Income

$636.00M

+53.6%

EBITDA

$1.94B

+73.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$14.29B

-7.7%

Accounts Receivable

$7.75B

+29.1%

Inventory

$5.91B

+4.3%

Long Term Debt

$14.68B

+0.3%

Short Term Debt

$3.01B

+28.0%

Return on Assets

9.35%

N/A

Return on Invested Capital

18.05%

N/A

Free Cash Flow

$1.48B

+23.6%

Operating Cash Flow

$2.04B

-12.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SNYSanofi
$44.60-1.63%
MCKMcKesson Corporation
$885.84-1.46%
HCAHCA Healthcare, Inc.
$493.88-1.16%
VRTXVertex Pharmaceuticals Incorporated
$454.08-0.87%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
ANNAAleAnna
$7.07+0.87%

Questions About GSK

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.